Improving VEGFR-2 Docking-Based Screening by Pharmacophore Postfiltering and Similarity Search Postprocessing

被引:16
作者
Planesas, Jesus M. [2 ]
Claramunt, Rosa M. [2 ]
Teixido, Jordi [1 ]
Borrell, Jose I. [1 ]
Perez-Nueno, Violeta I. [1 ]
机构
[1] Univ Ramon Llull, Grp Engn Mol, IQS, Barcelona, Spain
[2] Univ Nacl Educ Distancia, Dept Quim Organ & Bioorgan, Fac Ciencias, E-28040 Madrid, Spain
关键词
D O I
10.1021/ci1002763
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conventional docking-based virtual screening (VS) of chemical databases is based on the ranking of compounds according to the values retrieved by a scoring function (typically, the binding affinity estimation). However, using the most suitable scoring function for each kind of receptor pocket is not always an effective process to rank compounds, and sometimes neither to distinguish between correct binding modes from incorrect ones. To improve actives from decoys selection, here we propose a three-step VS protocol, which includes the conventional docking step, a pharmacophore postfilter step, and a similarity search postprocess. This VS protocol is retrospectively applied to VEGFR-2 (Kdr-kinase) inhibitors. The resulting docking poses calculated using the Alpha HB scoring function implemented in MOE are postfiltered according to defined pharmacophore interactions (structure based). The Selected poses are again ranked according to their molecular similarity (MACCS fingerprint) to the cognate ligand. Results show that both the overall and early VS performance improve the application of this protocol.
引用
收藏
页码:777 / 787
页数:11
相关论文
共 48 条
  • [31] Combining docking with pharmacophore filtering for improved virtual screening
    Peach, Megan L.
    Nicklaus, Marc C.
    [J]. JOURNAL OF CHEMINFORMATICS, 2009, 1
  • [32] Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors
    Peifer, Christian
    Selig, Roland
    Kinkel, Katrin
    Ott, Dimitri
    Totzke, Frank
    Schaechtele, Christoph
    Heidenreich, Regina
    Roecken, Martin
    Schollmeyer, Dieter
    Laufer, Stefan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3814 - 3824
  • [33] AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts
    Polverino, Anthony
    Coxon, Angela
    Starnes, Charlie
    Diaz, Zobedia
    DeMelfi, Thomas
    Wang, Ling
    Bready, James
    Estrada, Juan
    Cattley, Russell
    Kaufman, Stephen
    Chen, Danlin
    Gan, Yongmei
    Kumar, Gondi
    Meyer, James
    Neervannan, Sesha
    Alva, Gonzalo
    Talvenheimo, Jane
    Montestruque, Silvia
    Tasker, Andrew
    Patel, Vinod
    Radinsky, Robert
    Kendall, Richard
    [J]. CANCER RESEARCH, 2006, 66 (17) : 8715 - 8721
  • [34] Design, synthesis, and evaluation of orally active Benzimidazoles and Benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
    Potashman, Michele H.
    Bready, James
    Coxon, Angela
    DeMelfi, Thomas M., Jr.
    DiPietro, Lucian
    Doerr, Nicholas
    Elbaum, Daniel
    Estrada, Juan
    Gallan, Paul
    Germain, Julie
    Gu, Yan
    Harmange, Jean-Christophe
    Kaufman, Stephen A.
    Kendall, Rick
    Kim, Joseph L.
    Kumar, Gondi N.
    Long, Alexander M.
    Neervannan, Seshadri
    Patel, Vinod F.
    Polverino, Anthony
    Rose, Paul
    van der Plas, Simon
    Whittington, Douglas
    Zanon, Roger
    Zhao, Huilin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4351 - 4373
  • [35] Pradeep C R, 2005, Integr Cancer Ther, V4, P315, DOI 10.1177/1534735405282557
  • [36] PUJADAS G, 2008, CURR PHARM ANAL, V1, P1
  • [37] Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
    Pytel, Dariusz
    Sliwinski, Tomasz
    Poplawski, Tomasz
    Ferriola, Deborah
    Majsterek, Ireneusz
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (01) : 66 - 76
  • [38] Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data
    Rohrer, Sebastian G.
    Baumann, Knut
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (02) : 169 - 184
  • [39] Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[ 2,3-b] pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor
    Ruel, Rejean
    Thibeault, Carl
    L'Heureux, Alexandre
    Martel, Alain
    Cai, Zhen-Wei
    Wei, Donna
    Qian, Ligang
    Barrish, Joel C.
    Mathur, Arvind
    D'Arienzo, Celia
    Hunt, John T.
    Kamath, Amrita
    Marathe, Punit
    Zhang, Yueping
    Derbin, George
    Wautlet, Barri
    Mortillo, Steven
    Jeyaseelan, Robert, Sr.
    Henley, Benjamin
    Tejwani, Ravindra
    Bhide, Rajeev S.
    Trainor, George L.
    Fargnoli, Joseph
    Lombardo, Louis J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2985 - 2989
  • [40] Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase
    Sammond, DM
    Nallor, KE
    Veal, JM
    Nolte, RT
    Wang, LP
    Knick, VB
    Rudolph, SK
    Truesdale, AT
    Nartey, EN
    Stafford, JA
    Kumar, R
    Cheung, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) : 3519 - 3523